Harmony Biosciences Aktie
WKN DE: A2QBSF / ISIN: US4131971040
|
04.08.2026 13:48:10
|
Harmony Biosciences Holdings, Inc Q2 Profit Climbs
(RTTNews) - Harmony Biosciences Holdings, Inc (HRMY) released earnings for its second quarter that Increased, from last year
The company's earnings totaled $75.43 million, or $1.28 per share. This compares with $39.78 million, or $0.68 per share, last year.
The company's revenue for the period rose 30.3% to $261.28 million from $200.49 million last year.
Harmony Biosciences Holdings, Inc earnings at a glance (GAAP) :
-Earnings: $75.43 Mln. vs. $39.78 Mln. last year. -EPS: $1.28 vs. $0.68 last year. -Revenue: $261.28 Mln vs. $200.49 Mln last year.
-Guidance: Full year revenue guidance: $ 1.0 B To $ 1.04 B
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Harmony Biosciences
|
06.05.26 |
Ausblick: Harmony Biosciences legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
|
23.02.26 |
Ausblick: Harmony Biosciences stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |
Analysen zu Harmony Biosciences
Aktien in diesem Artikel
| Harmony Biosciences | 39,52 | 1,33% |
|